BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 10 analysts with an average price target of $52.44. This is a potential upside of $24.52 (87.82%) from yesterday's end of day stock price of $27.92.

Beam Therapeutics 's activity chart (see below) currently has 119 price targets and 92 ratings on display. The stock rating distribution of BEAM is 31.58% HOLD and 68.42% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.31% with an average time for these price targets to be met of 88.33 days.

Highest price target for BEAM is $80, Lowest price target is $20, average price target is $43.33.

Most recent stock forecast was given by MICHAEL YEE from UBS on 07-Jan-2026. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 6 are a HOLD (31.58%), 13 are a BUY (68.42%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Dec-2023

$28

$0.08 (0.29%)

$30

1 months 7 days ago
(07-Jan-2026)

4/4 (100%)

$-0.93 (-3.21%)

133

Buy Since 23-Jul-2024

$80

$52.08 (186.53%)

$80

4 months 4 days ago
(10-Oct-2025)

0/9 (0%)

$53.68 (203.95%)

Buy Since 12-Mar-2025

5 months 26 days ago
(19-Aug-2025)

1/10 (10%)

$12.38 (46.51%)

118

Hold Since 10-Aug-2022

$21

$-6.92 (-24.79%)

$25

6 months 8 days ago
(06-Aug-2025)

11/11 (100%)

$2.7 (14.75%)

145

Buy Since 05-Jan-2022

$55

$27.08 (96.99%)

$78

9 months 7 days ago
(07-May-2025)

0/4 (0%)

$38.77 (238.88%)

Show more analysts

Please expand the browser size to see the chart

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 88.33 days on average for the stock forecasts to be realized with a an average price target met ratio 40.31

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Patrick Trucchio with highest potential upside - $52.08

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Luca Issi with lowest potential downside - -$7.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?